Shell Announces Withdrawal From New Offshore Wind Development Projects

In a significant strategic shift, Shell has declared it will not pursue any new offshore wind projects, marking a notable retreat from renewable energy initiatives under the leadership of Chief Executive Wael Sawan. The oil major confirmed its commitment to maintaining existing wind farms in the Netherlands whilst continuing development of current pipeline projects across Europe, the US and the UK.

The company’s stance, revealed on Wednesday, emphasises its intention to “maximise the value of existing renewable generation platforms.” Shell maintains interest in power purchase agreements where commercial terms prove favourable, alongside potential equity positions given compelling investment cases.

This strategic realignment emerges from an internal business review aimed at cost reduction, strategy simplification, and enhanced returns. The move mirrors similar actions by industry peer BP, which recently listed its US onshore wind portfolio for sale.

The offshore wind sector has faced considerable headwinds, with rising costs and supply chain constraints impacting profitability. Major player Ørsted reduced its 2030 growth targets after abandoning two US offshore wind projects last year, while Equinor has scaled back early-stage developments in certain markets.

Shell’s renewable energy portfolio currently encompasses 3.4GW of capacity globally, sufficient to power 16 million UK homes annually. The company operates or is constructing 2GW of offshore wind capacity, with an additional 7.9GW in development. As part of its restructuring, Shell Energy will be divided into separate generation and trading units to streamline operations.

The announcement reflects broader industry challenges, particularly as rising interest rates impact the viability of projects requiring substantial upfront investment. Industry expert Jérôme Guillet notes a growing selectivity among utilities regarding offshore wind investments, with early-stage development facing particular difficulties.

Post Disclaimer

The following content has been published by Stockmark.IT. All information utilised in the creation of this communication has been gathered from publicly available sources that we consider reliable. Nevertheless, we cannot guarantee the accuracy or completeness of this communication.

This communication is intended solely for informational purposes and should not be construed as an offer, recommendation, solicitation, inducement, or invitation by or on behalf of the Company or any affiliates to engage in any investment activities. The opinions and views expressed by the authors are their own and do not necessarily reflect those of the Company, its affiliates, or any other third party.

The services and products mentioned in this communication may not be suitable for all recipients, by continuing to read this website and its content you agree to the terms of this disclaimer.